Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares, rose in value on Wednesday, July 09, with the stock price up by 12.43% to the previous day’s close as strong demand from buyers drove the stock to $1.99.
Actively observing the price movement in the last trading, the stock closed the session at $1.77, falling within a range of $1.8 and $2.01. The value of beta (5-year monthly) was 0.863. Referring to stock’s 52-week performance, its high was $12.51, and the low was $1.64. On the whole, IOVA has fluctuated by -2.93% over the past month.
With the market capitalization of Iovance Biotherapeutics Inc currently standing at about $664.53 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 287.11M, with a low estimate of 55.16M and a high estimate of 75.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 67.14M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IOVA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IOVA currently trading nearly 2.98% and -7.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.49, while the 7-day volatility ratio is showing 6.79% which for the 30-day chart, stands at 7.24%. Furthermore, Iovance Biotherapeutics Inc (IOVA)’s beta value is 0.84.
A comparison of Iovance Biotherapeutics Inc (IOVA) with its peers suggests the former has fared considerably weaker in the market. IOVA showed an intraday change of 12.43% in last session, and over the past year, it shrunk by -73.11%%.
Data on historical trading for Iovance Biotherapeutics Inc (NASDAQ:IOVA) indicates that the trading volumes over the past 10 days have averaged 10.93 and over the past 3 months, they’ve averaged 13.49 million. According to company’s latest data on outstanding shares, there are 333.93 million shares outstanding.
Nearly 18.70% of Iovance Biotherapeutics Inc’s shares belong to company insiders and institutional investors own 64.21% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 90.96 million shares as on 2025-06-13, resulting in a short ratio of 6.77. According to the data, the short interest in Iovance Biotherapeutics Inc (IOVA) stood at 2983.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 77.02 million. The stock has fallen by -72.66% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IOVA stock heading into the next quarter.
